EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study

Hanne Ludt Fossmo iD, Hilde Stendal Robinson iD, Karianne Grüner Bjåstad, Kristin Nielsen Varhaug, Jan C Frich iD, Kristin Ørstavik iD

European Journal of Neurology · 2026-11 · 33 (11)

DOI: 10.1111/ene.70799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 30.10.2026. Verfasst von Hanne Ludt Fossmo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences and Interdisciplinary Health Sciences, Institute of Health and Society, Faculty of Medicine, University of Oslo,…. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Upper Extremity, Muscle Strength. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Norwegian Centre for Rare Diseases research fund, Norwegian Neuromuscular Diseases Association research fund, Sophie and Leif Torps research fund for Myotonic Dystrophy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myotonic dystrophy Type 1 (DM1) is a multisystem neuromuscular disorder with progressive distal and proximal weakness, including in the upper limbs. Limited research has been conducted on hand function and outcome measures.

Methods

Eighty nine adult DM1 participants were included in this cross‐sectional study. The study describes upper limb strength and function and examines associations between motor impairments and clinical outcome measures, including comparing strength measurement methods. Disease severity was classified with the muscular impairment rating scale (MIRS) and the Brooke upper extremity scale was used as a classification scale of upper limb function. Muscle strength was measured using handheld dynamometers, and fine motor function with the Nine‐Hole Peg Test and Nut and Bolt task. Upper limb function was rated with the Revised Upper Limb Module and global motor function with the Motor Function Measure 32. Patient‐reported outcome measures included ABILHAND‐NMD, ACTIVLIM, and the Myotonia behavior scale.

Results

Participants showed a wide spectrum of motor impairment from minimal distal to severe proximal weakness. Strength measures correlated significantly with functional tests, while PROMs reflected perceived limitations but showed ceiling effects. Disease duration correlated with muscle strength and upper limb function, while age and subtype were less important. Myotonia severity showed only weak correlation with functional outcomes.

Conclusion

No single measure fully captures upper limb function in DM1. A combination of strength testing, dexterity tasks, and PROMs provides a multidimensional assessment framework. Muscle strength assessment remains essential, and these findings support integrating multiple standardized measures for clinical trial endpoints and therapeutic evaluation in DM1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyUpper ExtremityMuscle StrengthHumansFemaleCross-Sectional StudiesMaleAdultMiddle AgedSeverity of Illness IndexAgedYoung AdultOutcome Assessment, Health CarePatient Reported Outcome Measures

Stichwörter der Autor:innen

muscle strengthmyotonic dystrophy 1neuromuscular diseasesoutcome assessmentupper extremity

Autor:innen und Institutionen

  • Department of Public Health Sciences and Interdisciplinary Health Sciences, Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Section for Rare Neurological Disorders and EMAN, Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Norwegian Center for Rare Diseases, Frambu, Siggerud, Norway.
  • Vikersund Rehabilitation Center, Vikersund, Norway.
  • Nordmøre and Romsdal Hospital, Hjelset, Norway.
  • Department of Neurology, Haukeland University Hospital, Bergen, Norway.

ORCID-Profile: Hanne Ludt Fossmo, Hilde Stendal Robinson, Jan C Frich, Kristin Ørstavik

Förderung

  • Norwegian Centre for Rare Diseases research fund
  • Norwegian Neuromuscular Diseases Association research fund
  • Sophie and Leif Torps research fund for Myotonic Dystrophy

Zitieren

APA

Fossmo, H. L., Robinson, H. S., Bjåstad, K. G., Varhaug, K. N., Frich, J. C., & Ørstavik, K. (2026). Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study. European Journal of Neurology, 33(11). https://doi.org/10.1111/ene.70799

Vancouver

Fossmo HL, Robinson HS, Bjåstad KG, Varhaug KN, Frich JC, Ørstavik K. Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study. European Journal of Neurology. 2026;33(11). doi:10.1111/ene.70799

BibTeX
@article{Fossmo2026,
  author = {Fossmo, Hanne Ludt and Robinson, Hilde Stendal and Bjåstad, Karianne Grüner and Varhaug, Kristin Nielsen and Frich, Jan C and Ørstavik, Kristin},
  title = {Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross‐Sectional Study},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {11},
  doi = {10.1111/ene.70799}
}
Kostenlos starten →